NCT02046200View on ClinicalTrials.gov

Development of Ivermectin for Alcohol Use Disorders

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Alcohol Use Disorder
Interventions
DRUG

Ivermectin

Ivermectin is a semi-synthetic macrocyclic lactone used worldwide as a broad-spectrum antiparasitic avermectin.

DRUG

Placebo

Matched placebo

DRUG

Alcohol

Trial Locations (1)

90095

UCLA Addictions Laboratory, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT02046200 - Development of Ivermectin for Alcohol Use Disorders | Biotech Hunter | Biotech Hunter